Sign in

NCT05225428Completed

Video Education With Result Dependent dIsclosure

Source: ClinicalTrials.gov · Last updated 19 Oct 2026

Brief summary (registry, in English)

The overall study objective of this trial study is to identify and evaluate strategies to improve the accessibility of the video education with result dependent disclosure (VERDI) model, increasingly utilized as a pre-genetic testing (pretest) education alternative in clinical practice, to better serve a more diverse patient population at risk for hereditary cancers.

Status (registry)
Completed
Study type
Interventional
Enrollment
1334 (actual)
First submitted
21 Dec 2021
Start date
4 Aug 2022
Primary completion date
1 Sept 2026
Lead sponsor
Dana-Farber Cancer Institute
NCT number
NCT05225428

What you commit to

  • Study type: Interventional
  • Participants enrolled: 1334
  • From 4 Aug 2022 to the primary completion date, 1 Sept 2026
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Prior germline genetic testing

Other illness

  • Prior cancer genetic testing
  • Active hematologic malignancy (e.g. chronic lymphocytic leukemia)

Other

  • Currently pregnant
  • Currently incarcerated

Who the study is looking for

  • Age ≥ 18 years
  • Current or prior diagnosis of breast cancer, ovarian cancer, pancreatic cancer, prostate cancer, colorectal cancer, renal cancer, melanoma, or sarcoma
  • Ability to understand spoken or written English or Spanish in a healthcare context
  • Ability to understand and the willingness to sign a written informed consent document
  • Black or Latinx (qualitative assessment study only)

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Dana-Farber Cancer Institute
Coordinator of this site? Confirm its status
BostonUnited StatesUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.